Business
Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders
Australis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders.
About this update from Australis Capital Inc.
[{"type":"text","content":"\n\n\n\nAustralis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nAustralis Warns That Those Feigning Concern With Passport Transaction Have Selfish Motivations; Their Inaccurate and Misleading Communications Should Not Be Relied on by Australis Shareholders\nPR Newswire\nLAS VEGAS, July 23, 2020\n\n\n\nLAS VEGAS, July 23, 2020 /PRNewswire/ - Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (\"AUSA\" or the \"Company\") today warned shareholders about the motivations of a group of shareholders including Roger Sykes (\"Sykes\") 1703469 Alberta Ltd., Duke Fu, Amy Fu and Green Therapeutics LLC (\"Green Therapeutics\") (collectively the \"Concerned Shareholders\"), related to the Company's proposed acquisition of Passport Technology Inc. (\"Passport\"). \n\n \n \n \n \n \n \n\n \nAustralis is concerned about inaccurate and misleading information coming from those with alternative agendas that could harm the interests of all AUSA shareholders. Accordingly, the Company feels a responsibility to warn shareholders to disregard the information disseminated by the self-professed Concerned Shareholders. \nShareholders should note that all but one of the members of the dissident group are involved in litigation against Australis alleging breach of contract, the primary remedy sought being the rescission of the disputed contract and the return of Australis' common shares to the Company. This group's expressions of concern for the long-term interests of shareholders of the Company are spurious at best given that they would no longer be shareholders of the Company if their legal maneuvering is successful.  In that regard, AUSA shareholders are right to be concerned by the following facts and sequence of events: \nOn June 26, Sykes issued the initial Concerned Shareholders press release, On June 30, Green Therapeutics announced litigation against Australis with an objective to unwind the deal it ma...